Showing results (1-10 of 60) with videos related to

Sort By:
Pageof 6
International Journal of Environmental Research and Public Health|May 14, 2022
Methodological Investigation of Time Perspective Scoring and Quality of Life among Individuals with Multiple SclerosisEllen Carl, Alina Shevorykin, Amylynn Liskiewicz
Ultrasound in Medicine & Biology|May 23, 2018
Jugular Venous Flow Quantification Using Doppler SonographyKaren Marr, Dejan Jakimovski, Marcello Mancini, et al.
International Journal of Environmental Research and Public Health|August 27, 2021
Future Thinking Priming Especially Effective at Modifying Delay Discounting Rates among Cigarette SmokersAlina Shevorykin, Warren K Bickel, Ellen Carl, et al.
Journal of the National Cancer Institute. Monographs|July 17, 2025
Developing, implementing, and disseminating best practices for enhanced collection of sexual orientation and gender identity among cancer patients to catalyze innovative cancer control researchMaansi Bansal-Travers, Ellen Carl, Sarah Mullin, et al.
Journal of Neurology|September 8, 2011
Patterns of dietary and herbal supplement use by multiple sclerosis patientsKerri O'Connor, Bianca Weinstock-Guttman, Ellen Carl, et al.
Journal of the Neurological Sciences|April 9, 2018
Effect of teriflunomide on gray and white matter brain pathology in multiple sclerosis using volumetric and diffusion-tensor imaging MRI measuresRobert Zivadinov, Niels Bergsland, Jesper Hagemeier, et al.
CNS Drugs|May 17, 2018
The Effect of Glatiramer Acetate on Retinal Nerve Fiber Layer Thickness in Patients with Relapsing-Remitting Multiple Sclerosis: A Longitudinal Optical Coherence Tomography StudyRobert Zivadinov, Eleonora Tavazzi, Jesper Hagemeier, et al.
Journal of Neuroimmunology|January 21, 2012
Associations of moderate alcohol consumption with clinical and MRI measures in multiple sclerosisMathew Foster, Robert Zivadinov, Bianca Weinstock-Guttman, et al.
Therapeutic Advances in Neurological Disorders|November 26, 2020
Slowing of brain atrophy with teriflunomide and delayed conversion to clinically definite MSRobert Zivadinov, Michael G Dwyer, Ellen Carl, et al.
Journal of Alternative and Complementary Medicine (New York, N.Y.)|March 3, 2018
Complementary and Alternative Medicine Usage by Multiple Sclerosis Patients: Results from a Prospective Clinical StudySoohyun Kim, Lawrence Chang, Bianca Weinstock-Guttman, et al.
Pageof 6